Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients

Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients

Background: Several studies suggest a role of gut microbiota in colorectal cancer (CRC) initiation and progression. Vitamin D (vitD) blood levels are also inversely correlated with CRC risk and prognosis. However, these factors’ interplay remains unknown. Methods: 74 CRC patients after standard trea...

Full description

Bibliographic Details
Main Authors:	Federica Bellerba, Davide Serrano, Johansson Harriet, Chiara Pozzi, Nicola Segata, Amir NabiNejad, Elisa Piperni, Patrizia Gnagnarella, Debora Macis, Valentina Aristarco, Chiara A. Accornero, Paolo Manghi, Aliana Guerrieri Gonzaga, Roberto Biffi, Luca Bottiglieri, Cristina Trovato, Maria Giulia Zampino, Federica Corso, Rino Bellocco, Sara Raimondi, Maria Rescigno, Sara Gandini
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Neoplasia: An International Journal for Oncology Research
Subjects:	Colorectal cancer Microbiome Microbiota Vitamin D Sex Gender
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558622000689

Similar Items

Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial
by: Davide Serrano, et al.
Published: (2023-06-01)

Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.
by: Aliana Guerrieri-Gonzaga, et al.
Published: (2024-01-01)

Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer
by: Aliana Guerrieri-Gonzaga, et al.
Published: (2024-01-01)

Personality Factors in Colorectal Cancer: A Systematic Review
by: Federica Galli, et al.
Published: (2021-11-01)

Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models
by: Federica Maione, et al.
Published: (2024-06-01)

Gut eukaryotic virome in colorectal carcinogenesis: Is that a trigger?
by: Luca Massimino, et al.
Published: (2021-01-01)

Advancements in 3D In Vitro Models for Colorectal Cancer
by: Sara Vitale, et al.
Published: (2024-08-01)

High dietary inflammatory index associates with inflammatory proteins in plasma
by: Elisa Mattavelli, et al.
Published: (2024-02-01)

Sports activity limitation during the COVID-19 pandemic in young Italian athletes: impact on mental health in children, adolescents, and young adults
by: Elisa Tomezzoli, et al.
Published: (2023-08-01)

Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion
by: Angélica Díaz-Basabe, et al.
Published: (2024-12-01)

Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis.
by: Oriana D'Ecclesiis, et al.
Published: (2022-01-01)

An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer
by: Maria Laura De Angelis, et al.
Published: (2022-06-01)

Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model
by: Michela Murdocca, et al.
Published: (2019-09-01)

The Role of <i>Fusobacterium nucleatum</i> in Oral and Colorectal Carcinogenesis
by: Pamela Pignatelli, et al.
Published: (2023-09-01)

Estrogen-related differences in antitumor immunity and gut microbiome contribute to sexual dimorphism of colorectal cancer
by: Georgia Lattanzi, et al.
Published: (2024-12-01)

Altered Fecal Small RNA Profiles in Colorectal Cancer Reflect Gut Microbiome Composition in Stool Samples
by: Sonia Tarallo, et al.
Published: (2019-10-01)

NK Cell-Based Immunotherapy in Colorectal Cancer
by: Mariella Della Chiesa, et al.
Published: (2022-06-01)

Viruses in the Heart: Direct and Indirect Routes to Myocarditis and Heart Failure
by: Colton R. Martens, et al.
Published: (2021-09-01)

Anthocyanins in Colorectal Cancer Prevention. A Systematic Review of the Literature in Search of Molecular Oncotargets
by: Nevenka Medic, et al.
Published: (2019-06-01)

Chemokines—What Is Their Role in Colorectal Cancer?
by: Sara Pączek MCM, et al.
Published: (2020-02-01)

Plasma prolactin in patients with colorectal cancer
by: Moemeni Mehrnush, et al.
Published: (2004-12-01)

A cross-sectional and prospective cohort study of the role of schools in the SARS-CoV-2 second wave in Italy
by: Sara Gandini, et al.
Published: (2021-06-01)

Beware of regional heterogeneity when assessing the role of schools in the SARS-CoV-2 second wave in Italy—Authors´ reply.
by: Sara Gandini, et al.
Published: (2021-09-01)

Investigating trait emotional intelligence and perceived support from family and friends as buffering factors against disordered eating behaviours and poor glycaemic control in adolescents with type 1 diabetes
by: Federica Ambrosini, et al.
Published: (2024-12-01)

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
by: Elisa Grassi, et al.
Published: (2021-06-01)

Zebrafish Patient-Derived Xenograft Model to Predict Treatment Outcomes of Colorectal Cancer Patients
by: Gregorio Di Franco, et al.
Published: (2022-06-01)

To Stent or Not to Stent in Colorectal Cancer: That is Still the Question in Gastroenterology!
by: Sara Pires, et al.
Published: (2016-03-01)

Surgery for fistula-in-ano in a specialist colorectal unit: a critical appraisal
by: Sileri Pierpaolo, et al.
Published: (2011-11-01)

Small colorectal polyps as predecessors of colorectal cancer
by: А. К. Safiyeva, et al.
Published: (2018-07-01)

Surveillance of Colorectal Cancer (CRC) in Cystic Fibrosis (CF) Patients
by: Fabio Ingravalle, et al.
Published: (2021-05-01)

Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines
by: Schlicker Andreas, et al.
Published: (2012-12-01)

Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges
by: Chiara Tramontano, et al.
Published: (2023-04-01)

The Association between Periodontitis and Human Colorectal Cancer: Genetic and Pathogenic Linkage
by: Federica Di Spirito, et al.
Published: (2020-09-01)

Mir-675-5p supports hypoxia-induced drug resistance in colorectal cancer cells
by: Chiara Zichittella, et al.
Published: (2022-05-01)

Correction for Tarallo et al., “Altered Fecal Small RNA Profiles in Colorectal Cancer Reflect Gut Microbiome Composition in Stool Samples”
by: Sonia Tarallo, et al.
Published: (2020-02-01)

Correction for Tarallo et al., “Altered Fecal Small RNA Profiles in Colorectal Cancer Reflect Gut Microbiome Composition in Stool Samples”
by: Sonia Tarallo, et al.
Published: (2020-02-01)

HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes
by: Mariia Ivanova, et al.
Published: (2022-09-01)

A cost comparison of biologic treatment regimens for metastatic colorectal cancer in Italy
by: Sergio Iannazzo, et al.
Published: (2017-10-01)

Optimizing the first-line treatment for metastatic colorectal cancer
by: Sara Cherri, et al.
Published: (2023-10-01)

Role of the intestinal microbiome in colorectal cancer surgery outcomes
by: Lelde Lauka, et al.
Published: (2019-12-01)